Marshall Wace, LLP Viatris Inc Transaction History
Marshall Wace, LLP
- $74.4 Billion
- Q1 2025
A detailed history of Marshall Wace, LLP transactions in Viatris Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 259,454 shares of VTRS stock, worth $2.33 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
259,454
Previous 1,171,712
77.86%
Holding current value
$2.33 Million
Previous $14.6 Million
84.51%
% of portfolio
0.0%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding VTRS
# of Institutions
1,127Shares Held
943MCall Options Held
4.15MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.3 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$832 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$669 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az64.9MShares$583 Million3.35% of portfolio
-
State Street Corp Boston, MA61.5MShares$552 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $10.9B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...